HealthQuill Articles by: HealthQuill
Granules India announced the US Food & Drug Administration (US FDA) had approved an Abbreviated New Drug Application (ANDA) for losartan potassium tablets to treat high blood pressure.
Health Medical

Contraceptive pills ‘slightly’ increase risk of breast cancer, says study

Progestin-only contraceptive use increases breast cancer risk similarly to combined contraceptive use.

Read More
BioNTech, a German immunotherapy company, announced a strategic pact with OncoC4, a private firm, to develop and commercialise a drug to treat solid tumours.
Drugs Medical Pharma

BioNTech, OncoC4 in pact to develop drug for solid tumours

BioNTech, a German immunotherapy company, announced a strategic pact with OncoC4, a private firm, to develop and commercialise a drug to treat solid tumours.

Read More
An estimated 40,000 Somalians may have died last year in a drought caused by the failure of six consecutive rainy seasons, a new report by the Federal Ministry of Health, WHO and UNICEF stated.
Climate Health Pharma

Drought killed 40,000 Somalians last year, WHO-UNICEF-Govt study reports

An estimated 40,000 Somalians may have died last year in a drought caused by the failure of six consecutive rainy seasons, a new

Read More
About 800,000 people die yearly from diseases directly linked to unsafe water, inadequate sanitation, poor hygiene practices, and water-related hazards have increased at an alarming rate, the WHO stated.
Climate Health Pharma

Water-related diseases claim 800,000 people’s lives every year

About 800,000 people die yearly from diseases directly linked to unsafe water, inadequate sanitation, poor hygiene practices, and water-related hazards have increased at

Read More
The WHO’s scientific advisors have called on China to release all data relating to the COVID-19 origins after a new report hinted at the possibility of raccoon dogs as the first source of the virus.
Health Medical Pharma

WHO advisors urge China to release all data on COVID-19 origins

The WHO’s scientific advisors have called on China to release all data relating to the COVID-19 origins after a new report hinted at

Read More
India's Glenmark Pharmaceuticals has got the final approval by the USFDA for its generic prochlorperazine maleate tablets, the generic version of compazine of GlaxoSmithKline.
Drugs Medical Pharma

Glenmark’s drug to treat nausea, psychosis gets FDA nod

India's Glenmark Pharmaceuticals has got the final approval by the USFDA for its generic prochlorperazine maleate tablets, the generic version of compazine of

Read More
Eli Lilly announced that it had received US FDA approval for a tablet to treat a rare form of blood cancer.
Drugs Health Medical Pharma

FDA panel votes for full approval of Pfizer’s covid pill Paxlovid

The FDA’s advisory panel recommended full approval of Pfizer’s Covid antiviral treatment Paxlovid for high-risk adults.

Read More
The WHO slammed the Chinese authorities for not being transparent in sharing data related to COVID-19 origins and urged Beijing to conduct "investigations and share the results" with the global health agency.
Drugs Health Medical Pharma

New report opens a can of worms on COVID-19 origins, WHO steps in

The WHO slammed the Chinese authorities for not being transparent in sharing data related to COVID-19 origins and urged Beijing to conduct "investigations

Read More
Lupin Digital Health, a fully-owned subsidiary of Lupin, stated 83.3% of study patients with the acute coronary syndrome (ACS) maintained their vital signs in a programme aimed at valuing the efficacy of its Lyfe digital therapeutical platform.
Drugs Health Pharma

83.3% ACS patients achieve normality: Lupin Digital Health study

Lupin Digital Health, a fully-owned subsidiary of Lupin, stated 83.3% of study patients with the acute coronary syndrome (ACS) maintained their vital signs

Read More
Jubilant HollisterStier, a subsidiary of India's Jubilant Pharmova, has got Canada's nod for a partially repayable loan of CAD 23.8 million ($17.7 million) for expansion in Montreal.
Drugs Medical Pharma

Jubilant HollisterStier gets $17.7 million Canadian funding

Jubilant HollisterStier, a subsidiary of India's Jubilant Pharmova, has got Canada's nod for a partially repayable loan of CAD 23.8 million ($17.7 million)

Read More